Holen Sie sich die Stockscreener-App
24.83
2.60%
0.63
Schlusskurs vom Vortag:
$24.20
Offen:
$24.24
24-Stunden-Volumen:
474.84K
Relative Volume:
2.06
Marktkapitalisierung:
$1.57B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-143.59M
KGV:
-8.7937
EPS:
-2.8236
Netto-Cashflow:
$-119.47M
1W Leistung:
+5.44%
1M Leistung:
+3.50%
6M Leistung:
+51.40%
1J Leistung:
+18.01%
1-Tages-Spanne:
$23.76
$25.45
1-Wochen-Bereich:
$23.01
$26.20
52-Wochen-Spanne:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Vergleichen Sie PHVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
24.83 | 1.57B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-11 | Eingeleitet | Guggenheim | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Eingeleitet | Wedbush | Outperform |
| 2023-08-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Eingeleitet | Bryan Garnier | Buy |
| 2022-09-13 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2022-08-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Pharvaris Nv Aktie (PHVS) Neueste Nachrichten
What analysts say about Pharvaris NV stockDay Trading Setups & Free Double Digit Growth Tips - earlytimes.in
Pharvaris stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com UK
Is Pharvaris N.V. (9EN) stock attractive for growth fundsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Pharvaris NV (PHVS) can make a big difference with a little luck - Setenews
Why Pharvaris N.V. (9EN) stock could outperform next yearPortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
Why Pharvaris N.V. stock remains on watchlists2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com
Is Pharvaris N.V. (9EN) stock undervalued after correctionPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com
Can you recover from losses in Pharvaris N.V.Earnings Recap Summary & Consistent Profit Trading Strategies - newser.com
Why Pharvaris N.V. stock is in analyst buy zoneJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
How Pharvaris N.V. (9EN) stock trades in high volatilityMarket Movement Recap & High Accuracy Swing Entry Alerts - newser.com
Can Pharvaris N.V. (9EN) stock reach $200 price target2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 13:25:31 - newser.com
Citizens reiterates Market Outperform rating on Pharvaris stock ahead of trial data - Investing.com UK
Trading Systems Reacting to (PHVS) Volatility - news.stocktradersdaily.com
Will Pharvaris N.V. stock attract ESG investorsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
Why Bain Capital Is Selling Shares of This Biotech Stock Now - The Motley Fool
How sentiment analysis helps forecast Pharvaris N.V.July 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Pharvaris (NASDAQ:PHVS) Sees Strong Trading Volume After Analyst Upgrade - Defense World
Cantor Fitzgerald Boosts Earnings Estimates for Pharvaris - Defense World
What is Wedbush’s Estimate for Pharvaris FY2025 Earnings? - Defense World
Pharvaris FY2025 EPS Estimate Boosted by Leerink Partnrs - Defense World
Visual analytics tools that track Pharvaris N.V. performanceJuly 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
What recovery options are there for Pharvaris N.V.2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Wedbush Has Negative Estimate for Pharvaris FY2029 Earnings - Defense World
Is Pharvaris N.V. stock safe for conservative investorsIPO Watch & Verified Technical Trade Signals - newser.com
Custom watchlist performance reports with Pharvaris N.V.Portfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Pharvaris (NASDAQ:PHVS) Earns Buy Rating from HC Wainwright - Defense World
Can Pharvaris N.V. (9EN) stock deliver strong annual returnsJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Morgan Stanley Maintains Pharvaris N.V. (PHVS) Overweight Recommendation - MSN
Full technical analysis of Pharvaris N.V. stockWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Why Pharvaris N.V. (9EN) stock attracts HNW investors2025 Trading Recap & Free Community Supported Trade Ideas - Fundação Cultural do Pará
Technical signs of recovery in Pharvaris N.V.Trade Entry Report & Reliable Price Breakout Signals - newser.com
Finanzdaten der Pharvaris Nv-Aktie (PHVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):